Catalyst Wire Dossier Catalyst Wire Dossier

Vi-CRM197 vaccine

Vi-CRM197 conjugate vaccine · Novartis
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Vi-CRM197 vaccine, covering 2012-04-03 to 2014-04-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants [Phase 2]

See pricing